Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms

Findings from the STEP-BD

Joseph F. Goldberg, Roy H. Perlis, S. Nassir Ghaemi, Joseph R. Calabrese, Charles L. Bowden, Stephen Wisniewski, David J. Miklowitz, Gary S. Sachs, Michael E. Thase

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Objective: Practice guidelines have advised against treating patients with antidepressants during bipolar mixed states or dysphoric manias. However, few studies have examined the outcomes of patients with co-occurring manic and depressive symptoms who are treated with antidepressants plus mood stabilizing drugs. Method: The authors compared outcomes in patients with bipolar disorder who received a mood stabilizing agent with versus without an antidepressant for a bipolar depressive episode accompanied by >2 concurrent manic symptoms. The 335 participants were drawn from the first 2,000 enrollees in the National Institute of Mental Health (NIMH) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Kaplan-Meier survival curves and Cox regression models were used to compare time to recovery. General linear models examined the relationship between antidepressant use or mania symptom load at the study entry and mania or depression symptom severity at the 3-month follow-up. Results: Adjunctive antidepressant use was associated with significantly higher mania symptom severity at the 3-month follow-up. The probability of recovery at 3 months was lower among patients with higher baseline depression severity. Antidepressant use neither hastened nor prolonged time to recovery once potential confounding factors were covaried in a Cox regression model. Conclusions: In bipolar depression accompanied by manic symptoms, antidepressants do not hasten time to recovery relative to treatment with mood stabilizers alone, and treatment with antidepressants may lead to greater manic symptom severity. These findings are consistent with those from the STEP-BD randomized trial for pure bipolar depression, in which adjunctive antidepressants did not yield higher recovery rates than did mood stabilizer monotherapy.

Original languageEnglish (US)
Pages (from-to)1348-1355
Number of pages8
JournalAmerican Journal of Psychiatry
Volume164
Issue number9
DOIs
StatePublished - Sep 2007
Externally publishedYes

Fingerprint

Bipolar Disorder
Antidepressive Agents
Therapeutics
Depression
Proportional Hazards Models
National Institute of Mental Health (U.S.)
Excipients
Kaplan-Meier Estimate
Practice Guidelines
Linear Models
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms : Findings from the STEP-BD. / Goldberg, Joseph F.; Perlis, Roy H.; Ghaemi, S. Nassir; Calabrese, Joseph R.; Bowden, Charles L.; Wisniewski, Stephen; Miklowitz, David J.; Sachs, Gary S.; Thase, Michael E.

In: American Journal of Psychiatry, Vol. 164, No. 9, 09.2007, p. 1348-1355.

Research output: Contribution to journalArticle

Goldberg, JF, Perlis, RH, Ghaemi, SN, Calabrese, JR, Bowden, CL, Wisniewski, S, Miklowitz, DJ, Sachs, GS & Thase, ME 2007, 'Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD', American Journal of Psychiatry, vol. 164, no. 9, pp. 1348-1355. https://doi.org/10.1176/appi.ajp.2007.05122032
Goldberg, Joseph F. ; Perlis, Roy H. ; Ghaemi, S. Nassir ; Calabrese, Joseph R. ; Bowden, Charles L. ; Wisniewski, Stephen ; Miklowitz, David J. ; Sachs, Gary S. ; Thase, Michael E. / Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms : Findings from the STEP-BD. In: American Journal of Psychiatry. 2007 ; Vol. 164, No. 9. pp. 1348-1355.
@article{1bfc6a9ca464485e9d0a36c6368096de,
title = "Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD",
abstract = "Objective: Practice guidelines have advised against treating patients with antidepressants during bipolar mixed states or dysphoric manias. However, few studies have examined the outcomes of patients with co-occurring manic and depressive symptoms who are treated with antidepressants plus mood stabilizing drugs. Method: The authors compared outcomes in patients with bipolar disorder who received a mood stabilizing agent with versus without an antidepressant for a bipolar depressive episode accompanied by >2 concurrent manic symptoms. The 335 participants were drawn from the first 2,000 enrollees in the National Institute of Mental Health (NIMH) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Kaplan-Meier survival curves and Cox regression models were used to compare time to recovery. General linear models examined the relationship between antidepressant use or mania symptom load at the study entry and mania or depression symptom severity at the 3-month follow-up. Results: Adjunctive antidepressant use was associated with significantly higher mania symptom severity at the 3-month follow-up. The probability of recovery at 3 months was lower among patients with higher baseline depression severity. Antidepressant use neither hastened nor prolonged time to recovery once potential confounding factors were covaried in a Cox regression model. Conclusions: In bipolar depression accompanied by manic symptoms, antidepressants do not hasten time to recovery relative to treatment with mood stabilizers alone, and treatment with antidepressants may lead to greater manic symptom severity. These findings are consistent with those from the STEP-BD randomized trial for pure bipolar depression, in which adjunctive antidepressants did not yield higher recovery rates than did mood stabilizer monotherapy.",
author = "Goldberg, {Joseph F.} and Perlis, {Roy H.} and Ghaemi, {S. Nassir} and Calabrese, {Joseph R.} and Bowden, {Charles L.} and Stephen Wisniewski and Miklowitz, {David J.} and Sachs, {Gary S.} and Thase, {Michael E.}",
year = "2007",
month = "9",
doi = "10.1176/appi.ajp.2007.05122032",
language = "English (US)",
volume = "164",
pages = "1348--1355",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "9",

}

TY - JOUR

T1 - Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms

T2 - Findings from the STEP-BD

AU - Goldberg, Joseph F.

AU - Perlis, Roy H.

AU - Ghaemi, S. Nassir

AU - Calabrese, Joseph R.

AU - Bowden, Charles L.

AU - Wisniewski, Stephen

AU - Miklowitz, David J.

AU - Sachs, Gary S.

AU - Thase, Michael E.

PY - 2007/9

Y1 - 2007/9

N2 - Objective: Practice guidelines have advised against treating patients with antidepressants during bipolar mixed states or dysphoric manias. However, few studies have examined the outcomes of patients with co-occurring manic and depressive symptoms who are treated with antidepressants plus mood stabilizing drugs. Method: The authors compared outcomes in patients with bipolar disorder who received a mood stabilizing agent with versus without an antidepressant for a bipolar depressive episode accompanied by >2 concurrent manic symptoms. The 335 participants were drawn from the first 2,000 enrollees in the National Institute of Mental Health (NIMH) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Kaplan-Meier survival curves and Cox regression models were used to compare time to recovery. General linear models examined the relationship between antidepressant use or mania symptom load at the study entry and mania or depression symptom severity at the 3-month follow-up. Results: Adjunctive antidepressant use was associated with significantly higher mania symptom severity at the 3-month follow-up. The probability of recovery at 3 months was lower among patients with higher baseline depression severity. Antidepressant use neither hastened nor prolonged time to recovery once potential confounding factors were covaried in a Cox regression model. Conclusions: In bipolar depression accompanied by manic symptoms, antidepressants do not hasten time to recovery relative to treatment with mood stabilizers alone, and treatment with antidepressants may lead to greater manic symptom severity. These findings are consistent with those from the STEP-BD randomized trial for pure bipolar depression, in which adjunctive antidepressants did not yield higher recovery rates than did mood stabilizer monotherapy.

AB - Objective: Practice guidelines have advised against treating patients with antidepressants during bipolar mixed states or dysphoric manias. However, few studies have examined the outcomes of patients with co-occurring manic and depressive symptoms who are treated with antidepressants plus mood stabilizing drugs. Method: The authors compared outcomes in patients with bipolar disorder who received a mood stabilizing agent with versus without an antidepressant for a bipolar depressive episode accompanied by >2 concurrent manic symptoms. The 335 participants were drawn from the first 2,000 enrollees in the National Institute of Mental Health (NIMH) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Kaplan-Meier survival curves and Cox regression models were used to compare time to recovery. General linear models examined the relationship between antidepressant use or mania symptom load at the study entry and mania or depression symptom severity at the 3-month follow-up. Results: Adjunctive antidepressant use was associated with significantly higher mania symptom severity at the 3-month follow-up. The probability of recovery at 3 months was lower among patients with higher baseline depression severity. Antidepressant use neither hastened nor prolonged time to recovery once potential confounding factors were covaried in a Cox regression model. Conclusions: In bipolar depression accompanied by manic symptoms, antidepressants do not hasten time to recovery relative to treatment with mood stabilizers alone, and treatment with antidepressants may lead to greater manic symptom severity. These findings are consistent with those from the STEP-BD randomized trial for pure bipolar depression, in which adjunctive antidepressants did not yield higher recovery rates than did mood stabilizer monotherapy.

UR - http://www.scopus.com/inward/record.url?scp=34648827438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648827438&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.2007.05122032

DO - 10.1176/appi.ajp.2007.05122032

M3 - Article

VL - 164

SP - 1348

EP - 1355

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 9

ER -